Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to $1.4 million.

  • SOPHiA GENETICS's Depreciation & Amortization (CF) rose 3213.95% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 4381.96%. This contributed to the annual value of $4.0 million for FY2024, which is 4218.53% up from last year.
  • Per SOPHiA GENETICS's latest filing, its Depreciation & Amortization (CF) stood at $1.4 million for Q3 2025, which was up 3213.95% from $1.4 million recorded in Q2 2025.
  • Over the past 5 years, SOPHiA GENETICS's Depreciation & Amortization (CF) peaked at $1.4 million during Q2 2025, and registered a low of $220000.0 during Q1 2021.
  • In the last 5 years, SOPHiA GENETICS's Depreciation & Amortization (CF) had a median value of $675000.0 in 2023 and averaged $729631.6.
  • In the last 5 years, SOPHiA GENETICS's Depreciation & Amortization (CF) soared by 7070.42% in 2023 and then surged by 3213.95% in 2025.
  • Quarter analysis of 5 years shows SOPHiA GENETICS's Depreciation & Amortization (CF) stood at $307000.0 in 2021, then soared by 58.96% to $488000.0 in 2022, then skyrocketed by 66.19% to $811000.0 in 2023, then soared by 42.05% to $1.2 million in 2024, then rose by 21.7% to $1.4 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $1.4 million for Q3 2025, versus $1.4 million for Q2 2025 and $1.3 million for Q1 2025.